Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
SA Pharmaceutical Journal is Scopus-indexed (Q4, CiteScore 0.3), WoS ESCI. Published by Medpharm Publications.
Checked against the index lists dated .
ISSN 2220-1017Verify ISSN ↗2221-5875Verify ISSN ↗
Publisher: Medpharm Publications
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 170 / 191 | 11th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q4, CiteScore 0.3.
SA Pharmaceutical Journal is Q4 in Pharmaceutical Science (rank 170 of 191), by CiteScore 2025.
SA Pharmaceutical Journal is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.3, which places it in quartile Q4 at the 11th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.125, quartile Q4, with an H-index of 10.
SA Pharmaceutical Journal is published by Medpharm Publications. Its print ISSN is 2220-1017 and its online ISSN is 2221-5875.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
SA Pharmaceutical Journal has an h-index of 4 and a 2-year mean of 0.54 citations per paper (OpenAlex). Its Scopus CiteScore is 0.3, quartile Q4. On 2-year citations it ranks #131 of 177 Scopus journals in Pharmaceutical Science.
SA Pharmaceutical Journal published 48 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 54 research articles (2025–2026), authors are most often from South Africa (88%), India (4.6%) and Poland (1.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.